chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This was a booster shot.  I measured an extremely high pulse rate the first time I measured it roughly 24 hours after I had the injection.  My typical pulse is 68 bpm.  My pulse rate the entire evening (until midnight) was 120 bpm.
pt recv vax; rash on back; rash appeared of spider bites,being red,raised & swollen w/out pustules;
Woke up with loud ringing in left ear.  Makes it difficult to concentrate. Had permanent tinnitus already in right ear.  This is new and started the day after recieving the injection.
large patch of hives on left forearm 6" x 2", extending towards hand,  small bumps on back of  3rd and 4th fingers of right hand
Around 8:00am, I started to feel tired and weak. Through the course of the day, I ran a fever of 102.4. I had chills, a headache, very sore injection site, and the skin on my arms hurt. I was exhausted, but couldn't sleep. I took Tylenol, but it didn't seem to help much. I didn't have much of an appetite. Around 7:00pm, I no longer had chills but instead was very hot. About 2:00am, I woke up drenched in sweat, but felt so much better.
Following his booster on Nov 9, his white blood count soared to over 181,000 and platelets plummeted. Acute Leukemia diagnosed and he passed away on Dec 12. By Dec 6, was unable to function and was placed in hospice care.
gave 11 patients Moderna Covid-19 Vaccine doses  on 6Oct2021 from a vial that had been moved from frozen to refrigerated storage when they received them on 30Aug2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (gave 11 patients Moderna Covid-19 Vaccine doses on 6Oct2021 from a vial that had been moved from frozen to refrigerated storage when they received them on 30Aug2021) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 06-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (gave 11 patients Moderna Covid-19 Vaccine doses  on 6Oct2021 from a vial that had been moved from frozen to refrigerated storage when they received them on 30Aug2021). At the time of the report, PRODUCT STORAGE ERROR (gave 11 patients Moderna Covid-19 Vaccine doses  on 6Oct2021 from a vial that had been moved from frozen to refrigerated storage when they received them on 30Aug2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.
Violent head, joint and body pain, watery diarrhea, chills and sweats, extreme lethargy and sleepiness, confusion, abdominal pain, extreme nausea, loss of balance
No additional adverse symptoms reported; patient was inadvertently administered one dose of VARIVAX four days past its labeled expiry; This spontaneous report was received from a nurse and refers to a 12 month old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 18-MAR-2020, the patient was inadvertently vaccinated with one dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # R007695, expiration date 14-MAR-2020, subcutaneous (dose was not reported) for prophylaxis. Concomitant therapies included sterile diluent. The suspect vaccine was four days past its labeled expiry. No additional adverse symptoms reported. The outcome of expired product administered and was unknown.
This spontaneous report as received from a registered nurse refers to patients of unknown age and gender. Two doses of ZOSTAVAX (Lot number, dose and frequency was unknown) were improperly stored and administered to patients. After 25-NOV-2014, temperature range was 10.8 Fahrenheit degrees (F). The time frame was 48 minutes. No adverse events were reported. The outcome of the event was not reported. Follow up information has been received from the same nurse on 17-DEC-2014. The nurse reported that "several" doses (unspecified of how many doses and unspecified if it was the VARIVAX (Merck) or ZOSTAVAX or both) were administered after the temperature excursion. No adverse effect reported. No further information was provided. This is one of several reports received from the same reporter. Additional information is not expected because the nurse requested not to receive any additional follow-up.
10/23/2020 pt reported iching rash/ Hive of the Left arm, resolved in 1/2 days on 10/26/2020 10/27/2020 report to VAER
Patient complained of tingling of lips & tongue, tingling of throat w/ cough, tight breathing.  Cleared by EMS after supportive care.
Positive test several days PTA and arrived with worsening sypmtoms. Admit for COVID pna. Fully vaccinated. Placed on O2, steroids, singulair, zinc. Was able to wean to room air and discharge home.
Itchy rash in many areas of the body. Was prescribed Methylprednisolone pack on 4/14. Rash has not resolved as of 4/16.
OVER A PERIOD OF 1 HOUR: ELEVATED HEART RATE WHILE RESTING, 88-111 BMP; POUNDING HEART; SHORTNESS OF BREATH
Information has been received from a pharmacy intern concerning an 11 or 12 years old patient of unspecified gender. The patient's medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not reported. On 13-JAN-2015, the patient was vaccinated with the first dose in the Human Papillomavirus (HPV) series with GARDASIL (strength, dose, anatomical location, route of administration, lot number and expiration date were not provided) for prophylaxis. On an unspecified date in December 2016, the patient was vaccinated with the second dose in the HPV series with GARDASIL 9 (strength, dose, anatomical location, route of administration, lot number and expiration date were not provided) for prophylaxis. No adverse effects were reported. There was no product quality complaint involved. Additional information has been requested.
Pt states that prior to receiving vaccine he was having PND and rhinorrhea in the morning which had resolved before he arrived to the vax site. After receiving shot at 1023 pt states he started feeling fatigued, he had intermittent CP located at center of chest, non-radiating that lasted about 10 minutes, he also had a scratchy throat. Pt was given a benadryl PO at 1045. On PE, pt mild pharyngeal erythema, CTAB, RRR, CP had resolved and was non-reproducible, VSS, spO2 98, HR 81. Pt was advised to go to ED or urgent care for further evaluation, by 1100 pt stated he felt fatigued, but had no other symptoms. Pt was walked outside the vaccine facility where he had said his wife would we waiting, wife was not found. Pt was advised to drive himself to the ED/UC and f/u with his PCM the tomorrow morning 02JUN20201, pt verbalized understanding.
After shot my arthritis got worse, resulting in having both knees replaced. Discharge Summary received on 3/07/2005 states DVT R Leg s/p total knee replacement. Medical Records received on 03/21/2005 states total R knee replacement due to severe DJD  degenerative joint disease. - 3/2/05 Medical records for 6/03 reviewed. Final diagnosis was 'DVT R LEG'. Chief complaint was 'fall, lac to head, no LOC". 3/3/05 Review of d/c summary confirms diagnosis of DJD and procedure of left total knee replacement.
This spontaneous report as received from a other health professional refers to an unspecified number of patients of unknown age. On an unknown date the patients were vaccinated with ROTATEQ lot # M040271, orally, for prophylaxis. On an unknown date the patients experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event was unknown. The reporter considered incorrect product storage and no adverse event to be not related to ROTATEQ. This was one of several reports received from the same source. Additional information has been requested. Sender's Comments: US-009507513-1708USA003517: US-009507513-1708USA004079: US-009507513-1708USA004081.
Information has been received from a physician concerning a 4 year old male pt who on 5/5/00 was vaccinated with 1 dose of Hep-B virus vaccine inactivated. Concomitant therapy included cefaclor and it was noted that the pt has tolerated cephalosporin antibiotics well in the past. On 5/5/00, the pt experienced "a generalized urticarial rash". He was taken to a local ER for treatment. Additional information has been requested.
The night that I received my third dose, I noticed that I started to have night sweats and that has never happened before. I was also very tired after the third dose. I'm still having night sweats form time to time.
This spontaneous report was received from a nurse practitioner refers to an approximately 15 year old patient. No relevant medical history of the patient was reported. On 09-APR-2009, the patient was vaccinated with GARDASIL dose 1 (strength, route and lot number were not reported). No concomitant medications were reported. The patient received the second dose of GARDASIL on 26-APR-2010 and the third dose on 30-NOV-2010 (strength, route and lot number were not reported). It was reported that the patient did not experience any adverse effects. There was no product quality complaint involved. The outcome was unknown. Additional information has been requested.
Swelling of injection site four hours after vaccination, burning, warm redness of about 6 inches in diameter around injection site, neck pain, nausea, stomach pain with cramping, diarrhea, fever, cold sweats, chills, heat flashes, headache, dizziness, light headedness, malaise
Two days after receiving 3 vaccines the patient developed symptoms of redness and burning in her hands and feet. Symptoms have continued intermittently. They have not resolved. She was seen in our office today.
STROKE; SHORT WINDED; This spontaneous report received from a patient concerned a 78 year old White and not Hispanic or Latino male. The patient's height, and weight were not reported. The patient's past medical history included blood clot in leg around 10 year ago, and concurrent conditions included high blood pressure, social drinker, hole in heart from birth, and non-smoker, and other pre-existing medical conditions included the patient had no known allergies. the patient did not have any drug abuse/illicit drug use.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, administered on left arm on 11-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included acetylsalicylic acid, atorvastatin, clopidogrel bisulfate, colecalciferol, escitalopram, finasteride, gabapentin, hydroxychloroquine sulfate, levothyroxine, lisinopril, thioctic acid, ticagrelor and verapamil hydrochloride were drug used for unknown indication.  On 12-APR-2021, the patient experienced headaches, which lasted 1 week. On 18-APR-2021, the patient had CT scan (computerized tomography) result was not reported. Patient was sent home for tension headache. On same day,  patient had also experienced no energy. On 19-APR-2021, the patient was Hospitalized for MRI (Magnetic resonance imaging) which showed patient had stroke within 5 days and also had plaque around the brain. Patient was started on Plavix and aspirin. On 21-APR-2021, the patient discharged from hospital. On same date, the patient went to cardiologist to have monitor placed where patient had another stroke and patient was readmitted to the hospital. patient was taken off Plavix and started on Lisinopril and placed on heart monitor. On 23-APR-2021, the patient was discharged from hospital. Patient was hospitalized for 5 days. On APR-2021 patient had experienced down hill, short winded and voice was gone. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from stroke, and had not recovered from short winded. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0. 20210518146-COVID-19 VACCINE AD26.COV2.S-Stroke. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY
COVID Pfizer 3rd shot on Oct 12, 2021. Vaginal Bleeding Oct 22-24, 2021
Rapid heartbeat; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Jul2021 at 13:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient had no past medical history. The patient did not have any allergies to food, medications, or other products. Concomitant medications included multi-vitamin for an unknown indication on an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Jun2021 at 13:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Jul2021 at 04:00, the patient experienced rapid heartbeat. The patient's heart speeds up and then it goes back to normal and then it speeds up and goes back to normal. When it speeds up it's a much stronger heartbeat then when it the normal heartbeat. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rapid heartbeat was not recovered at the time of reporting.   The batch/lot numbers for BNT162b2, were not provided and will be requested during follow up.
Felt a sharp pain in left shoulder a few hours after vaccine. Pain/dull ache has not gone away since (over three months). Have tried Advil, oral steroid, and next will be a cortisone shot. MRI showed a tear. If cortisone doesn't work then next step would be surgery.
she also reported experiencing soreness to her arm after administration of the first vaccine dose; This is a spontaneous report from a contactable nurse.  A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) , via an unspecified route of administration from an unspecified date, as a single dose for Covid-19 immunization. Medical history and concomitant medications were not reported.  The patient reported that she was scheduled to have a root canal near the time of her second covid vaccine dose and wanted to make sure and see if there were any contraindications known. She also reported experiencing soreness to her arm after administration of the first vaccine dose. The outcome of the event was not reported.
Sore arm for weeks after shot, still having a sore arm, no swelling or redness (right arm).
mother's leg started hurting after receiving the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (mother's leg started hurting after receiving the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (mother's leg started hurting after receiving the vaccine). At the time of the report, PAIN IN EXTREMITY (mother's leg started hurting after receiving the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  No treatment medication use was reported.
vaccination site warmth; red thing (swelling) on my arm is still the size of a flower; pains, aches, and redness at the injection site; redness at the injection site; had pains, aches, and redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (vaccination site warmth), INJECTION SITE SWELLING (red thing (swelling) on my arm is still the size of a flower), MYALGIA (pains, aches, and redness at the injection site), INJECTION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE PAIN (had pains, aches, and redness at the injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 19-Jan-2021, the patient experienced VACCINATION SITE WARMTH (vaccination site warmth), INJECTION SITE SWELLING (red thing (swelling) on my arm is still the size of a flower), MYALGIA (pains, aches, and redness at the injection site), INJECTION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE PAIN (had pains, aches, and redness at the injection site). At the time of the report, VACCINATION SITE WARMTH (vaccination site warmth), INJECTION SITE SWELLING (red thing (swelling) on my arm is still the size of a flower), MYALGIA (pains, aches, and redness at the injection site), INJECTION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE PAIN (had pains, aches, and redness at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported  Treatment for the events included Aspirin.  On 25-Mar-2021 the patient reported events after the second dose of the vaccine and commented that it took about three weeks for her arm to return to normal after each vaccine administration but that she has fully recovered.   Most recent FOLLOW-UP information incorporated above includes: On 25-Mar-2021: Initial Additional; Reporter's Comments: This case concerns a 72-year-old female who experienced NS expected events of injection site pain, injection site erythema, injection site swelling, and injection site warmth.  Event onset occurred the same day as the first dose of mRNA-1273. Treatment included aspirin. Events resolved, except for ongoing erythema. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Right arm red, hot, itchy with a large area of redness and a lump 2"x1".
The next morning post vax, the pt vomited times three, had fever most of the day to 103 and felt weak. By the evening, the pt felt much better. Able to eat a light dinner. Fever gone by next morning and feeling fine. Motrin given day 1 for increased temperature.
pt reported began feeling dizzy/ light headed during the recovery period. pt was noted by staff to be pale in color, pt was taken to triage area and attended by paramedics on site. decision was made by mid-lever provider to transport patient it the Emergency room for further evaluation because patient standing heart was increased to 200.
Headache, Myalgia first chills, then arm ache,5pm headaches and body aches; then night sweats and myalgias Narrative:
This spontaneous report as received from a licensed nurse practitioner refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions and allergies were not reported. On 20-SEP-2016, the patient was vaccinated with improperly stored ZOSTAVAX (dose and route were not reported) lot # L038926 and expiry date: 06-JUN-2017. No concomitant medications and no adverse events were reported. The call was due to a data logger. No further information was available. There was no product quality complaint (PQC) involved. This is one of the several reports received from the same reporter. Additional information has been requested.
After receiving his second injection, the patient developed a pruritic dermatitis that has not gone away. He has been to the ER twice for this complaint. No dysphagia or dyspnea. Patient very upset symptoms are persistent.
PATIENT IS UNDER THE RECOMMENDED AGE RANGE.  THE PATIENT'S AGE IS 16 AND 4 MONTHS.  THE VACCINE ERROR WAS FOUNDED BY THE PHARMACY THAT THE VACCINE IS PROVIDED BY AND ALSO DOES THE BILLING FOR THE VACCINE.  THE PHARMACY NOTIFIED THE MEDICAL OFFICE THE SAME DAY THAT THE VACCINE WAS ADMINSTERED ON 07/12/2021.  THE MEDICAL OFFICE NOTIFIED THE PATIENT THE FOLLOWING DAY 07/13/2021.  ACCORDING TO THE MEDICAL OFFICE THE PATIENT DID NOT REPORT ANY SIDE EFFECTS AFTER THE VACCINE WAS ADMINSTERED.  PHARMACY ALSO CALLED MODERNA COMPANY AND SPOKE WITH CUSTOMER SERVICE REPRESENTATIVE ADE.  HE TOLD THE PHARMACY TO SUBMIT A VAERS ADVERSE EVENT.  MODERNA COMPANY DOESNT HAVE ANY FURTHER INFORMATION REGARDING ANY ADVERSE EVENT.
Upon my 30 min observation , At about 5 minutes of receiving the vaccination I had a flush sensation from head to toe, increased HR that persisted, I informed RN at injection clinic. I was then hooked up to monitor , hr continued to sustain at 118 and bp increased to 150/90.  For the next two hours I had  continuous waves of increased hr to 118 and increased bp with nausea, chills and flushing.  The duration of the episodes lengthend as time progressed, the episodes lasted anywhere from 2-4 minutes. The amount of episodes I had was 4-5.  I was admitted to to the ER where I was administered Famitodine, steroids and Zofran, I had a EKG and was monitored for 8 hours .  I continued on steroids for 4 days.  The following  day I had PVC's and flushing.
Neck pain; Sore discomfort; Runny nose; Abdominal cramps; Sore arm; Fatigue; This is a spontaneous report from a contactable healthcare professional. A 38-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via intramuscular route in the left arm on 19Mar2021 at 10:30 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not tested positive for COVID-19. On 19Mar2021 at 1100, the patient experienced sore arm, fatigue, neck pain, sore discomfort, runny nose and abdominal cramps. It was reported that adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was reported that no treatment was taken for the events experienced. The clinical outcome of the events sore arm, fatigue, neck pain, sore discomfort, runny nose and abdominal cramps were resolving at the time of this report. No follow-up attempts are possible. No further information is expected.
Site redness, swelling, firm to touch, itching, approximately 5 inch diameter.
I began having an Ocular Migraine 2 days after my vaccine. It's an eye condition that causes brief attacks of blindness or visual problems like flashing lights in 1 eye. This migraine affected my left eye. I took Magnesium and it resolved it within minutes and it never came back.